Caplin Point Laboratories Limited (NSE:CAPLIPOINT)
India · Delayed Price · Currency is INR 2,517.40
+0.20 (0.01%)
Aug 31, 2026, 3:29 PM IST
Caplin Point Laboratories Market Cap
Caplin Point Laboratories has a market cap or net worth of 191.34 billion as of August 31, 2026. Its market cap has increased by 19.80% in one year.
Market Cap
191.34B
Enterprise Value
182.51B
Revenue
22.87B
Ranking
n/a
PE Ratio
28.76
Stock Price
2,517.40
ChartMarket Cap Chart
Since February 26, 2002, Caplin Point Laboratories's market cap has increased from 5.60M to 191.34B, an increase of 3,417,303.85%. That is a compound annual growth rate of 53.06%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 31, 2026 | 191.34B | 36.72% |
| Dec 31, 2025 | 139.95B | -26.39% |
| Dec 31, 2024 | 190.12B | 84.60% |
| Dec 29, 2023 | 102.99B | 90.47% |
| Dec 30, 2022 | 54.07B | -16.82% |
| Dec 31, 2021 | 65.01B | 69.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Emcure Pharmaceuticals | 351.91B |
| Wockhardt | 306.09B |
| Piramal Pharma | 284.54B |
| Eris Lifesciences | 179.75B |
| Cohance Lifesciences | 174.43B |
| Alivus Life Sciences | 172.53B |
| Alembic Pharmaceuticals | 164.11B |
| NATCO Pharma | 150.72B |